Matches in Nanopublications for { ?s ?p "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_provenance.
- NP158201.RAcaC87ZwdIpOF3_JaifEApnzLbGtn8C8fBX-HwdiUzfM130_assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP158201.RAcaC87ZwdIpOF3_JaifEApnzLbGtn8C8fBX-HwdiUzfM130_provenance.
- NP659792.RAsO8yEhTnLgh-JQJDrb4wcQ_uqFgw_CXRBakXtEVPqmw130_assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659792.RAsO8yEhTnLgh-JQJDrb4wcQ_uqFgw_CXRBakXtEVPqmw130_provenance.
- NP487513.RAW0pZH5ORqIsT8LkELvVs9QSk4gLsE7BHg8FFgVaeNgc130_assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487513.RAW0pZH5ORqIsT8LkELvVs9QSk4gLsE7BHg8FFgVaeNgc130_provenance.
- NP721372.RAWACQ19oMAYY3pBtPchsoz1JPGW4cGAt01zhCinbGNFI130_assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721372.RAWACQ19oMAYY3pBtPchsoz1JPGW4cGAt01zhCinbGNFI130_provenance.
- NP351407.RAPnFfAgy7RZ5lgDzilVk6mpIYRFyt2ZrLCKqmxx3VZxk130_assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351407.RAPnFfAgy7RZ5lgDzilVk6mpIYRFyt2ZrLCKqmxx3VZxk130_provenance.
- assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631469.RA-pVWHjgnDBBICA4yT2dKzqB04ntdqHVZbwW2-gftL8I130_provenance.
- assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.